Bankole, O.; Scambi, I.; Parrella, E.; Muccilli, M.; Bonafede, R.; Turano, E.; Pizzi, M.; Mariotti, R.
Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice. Int. J. Mol. Sci. 2022, 23, 1047.
https://doi.org/10.3390/ijms23031047
AMA Style
Bankole O, Scambi I, Parrella E, Muccilli M, Bonafede R, Turano E, Pizzi M, Mariotti R.
Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice. International Journal of Molecular Sciences. 2022; 23(3):1047.
https://doi.org/10.3390/ijms23031047
Chicago/Turabian Style
Bankole, Oluwamolakun, Ilaria Scambi, Edoardo Parrella, Matilde Muccilli, Roberta Bonafede, Ermanna Turano, Marina Pizzi, and Raffaella Mariotti.
2022. "Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice" International Journal of Molecular Sciences 23, no. 3: 1047.
https://doi.org/10.3390/ijms23031047
APA Style
Bankole, O., Scambi, I., Parrella, E., Muccilli, M., Bonafede, R., Turano, E., Pizzi, M., & Mariotti, R.
(2022). Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice. International Journal of Molecular Sciences, 23(3), 1047.
https://doi.org/10.3390/ijms23031047